Novel Inhaled Anesthetic Program

About Expanesthetics

Expanesthetics is a private, preclinical-stage biotech based in San Diego, focused on revolutionizing inhaled anesthesia through a proprietary discovery engine. The company's platform, rooted in research from UC Davis, uses molar water solubility to predict receptor activity and design anesthetics that target specific neural pathways to reduce side effects. It has generated a pipeline of novel drug candidates, including the first non-ether anesthetic in over 60 years to reach its stage, showing promising preclinical results such as maintaining normal blood pressure. Expanesthetics aims to address a large, underserved market dominated by decades-old generic drugs.

Therapeutic Areas

Other General Anesthesia Drugs